Therefore, in vivo models that accurately reflect tumors of pure oligodendroglioma histology, and in particular, tumors with IDH mutation, are still greatly needed to represent this disease, and more broadly, human gliomas with IDH mutations. This evidence concerns the gene IDH2 and central nervous system cancer.